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TRF2 Protects Human Telomeres
from End-to-End Fusions
their formation. However, other experiments suggest
that long G-strand tails are only present on half of the
chromosome ends, consistent with their being gener-
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ated by incomplete lagging-strand synthesis duringNew York, New York 10021
DNA replication (Wright et al., 1997).
Telomeres in somatic human cells shorten by 50±200
bp per cell division (Cooke and Smith, 1986; Harley etSummary
al., 1990; Hastie et al., 1990; reviewed in Harley, 1995).
Programmed telomere shortening in normal human cellsThe mechanism by which telomeres prevent end-to-
is probably best viewed as a tumor suppressor mecha-end fusion has remained elusive. Here, we show that
nism that limits thegrowth potential of transformed cellsthe human telomeric protein TRF2 plays a key role in
(reviewed in de Lange, 1998). In agreement, telomerethe protective activity of telomeres. A dominant nega-
length is strongly correlated with the proliferative capac-tive allele of TRF2 induced end-to-end chromosome
ity of normal human cells (Allsopp et al., 1992), the cata-fusions detectable in metaphase and anaphase cells.
lytic subunit of telomerase (hTRT/hEst2p) is up-regu-Telomeric DNA persisted at the fusions, demonstra-
lated in human tumors and immortalized cells (Meyersonting that TTAGGG repeats per se are not sufficient for
et al., 1997; Nakamura et al., 1997), and activation oftelomere integrity. Molecular analysis suggested that
telomerase in primary human cells results in the exten-the fusions represented ligation of telomeres that have
sion of cellular life span beyond the scheduled senes-
lost their single-stranded G-tails. Therefore, TRF2 may
cence point (Bodnar et al., 1998).
protect chromosome ends by maintaining the correct Loss of telomere function in human cells results in
structure at telomere termini. In addition, expression the formation of dicentric chromosomes and other ab-
of mutant forms of TRF2 induced a growth arrest with normalities created through end-to-end fusions (Counter
characteristics of senescence. The results raise the et al., 1992). Both in senescent cells and in tumor cells,
possibility that chromosome end fusions and senes- dicentric chromosomes, rings, and sister-chromatid fu-
cence in primary human cells may be caused by loss sions are correlated with critically shortened telomeres
by TRF2 from shortened telomeres. (reviewed in de Lange, 1995). These observations, taken
together with evidence for a protective role of telomeres
Introduction from yeast, ciliates, flies, and maize, have led to the
supposition that chromosome ends lacking telomeric
Based on genetic and cytological observations, Muller DNA fail to recruit a terminal protein complex required
(1938) and McClintock (1941 and 1942) reasoned that for their protection. However, there has been no direct
telomeres protect chromosomes from end-to-end fu- evidence for telomeric proteins that protect chromo-
sion. Telomeres are now understood tobe terminal com- some ends from end-to-end fusion, and it has remained
plexes of repetitive sequences and associated proteins obscure how such factors might act.
Two human telomeric DNA-binding proteins havethat distinguish natural chromosome ends from dam-
been identified. TRF1 was isolatedas a double-strandedaged DNA. Despite their extensive characterization in
TTAGGG repeat±binding protein from HeLa cells (Chongyeasts, ciliates, and mammals, the molecular mecha-
et al., 1995). This factor is a homodimeric protein withnism by which telomeres prevent end-to-end fusions is
a C-terminal helix-turn helix motif similar to the Myb andunclear. Here, we address this issue in human cells by
homeodomain DNA±binding folds (Bianchi et al., 1997;direct visualization of chromosome behavior after inter-
reviewed in Konig and Rhodes, 1997; Smith and deference with the function of a telomeric protein.
Lange, 1997). TRF2 carries a similar C-terminal MybHuman chromosome ends carry 2±30 kb of double-
motif but is different from TRF1 in that its N terminus isstranded TTAGGG repeats, which are necessary for telo-
very basic rather than acidic (Bilaud et al., 1997; Broccolimere function in somatic cells (Farr et al., 1991; Hanish
et al., 1997) (Figure 1). Both proteins bind specificallyet al., 1994). In the germline and in immortalized cells,
to double-stranded TTAGGG repeats in vitro and arethis sequence can be maintained by telomerase, a re-
located at telomeres in vivo. The two TRFs are ubiqui-verse transcriptase that adds TTAGGG repeats onto the
tously expressed, and current evidence indicates that39 ends of chromosomes (for review, Morin, 1996). The
most human telomeres contain both factors bound si-termini of human telomeres carry long (z150 nt) protru-
multaneously throughout the cell cycle (Chong et al.,sions of single-stranded TTAGGG repeats (Makarov et
1995; Broccoli et al., 1997; Smith and de Lange, 1997;
al., 1997; McElligott and Wellinger, 1997; Wright et al.,
van Steensel and de Lange, 1997) (this report, Broccoli,
1997), which are an effective substrate for telomerase
et al., unpublished data). TRF1 was recently inferred to
in vitro. According to one analysis (Makarov et al., 1997), be a negative regulator of telomere length maintenance
G-strand overhangs appear to be present at most chro- (van Steensel and deLange, 1997), because overexpres-
mosome ends and are maintained in cells lacking te- sion results in a gradual decline of telomere length, and
lomerase, suggesting that a 59-39 exonuclease acting inhibition of TRF1 generates a telomere elongation phe-
on the C-rich telomeric strand may be responsible for notype. Here, we document a key role for TRF2 in a
second function of telomeres: the protection of chromo-
some ends from end-to-end fusion.*To whom correspondence should be addressed.
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of the endogenous TRF2 protein was not affected by
doxycyclin (Figure 1B). Overexpression of full-length
TRF2 was also demonstrated by a gel-shift assay for
the detection of TTAGGG repeat±binding activity (data
not shown).
Consistent with previous experiments using epitope-
tagged protein (Broccoli et al., 1997), endogenous TRF2
protein localized predominantly to telomeres, as evident
from the punctate pattern in interphase and the terminal
localization of TRF2 signals in many of the metaphase
chromosomes (Figures 2A and 2B). Furthermore, most
of the TRF2 pattern colocalized with TRF1 in interphase
nuclei (Figures 2C and 2D), but further analysis will be
required to establish whether all telomeres contain both
TRF1 and TRF2 at all times.
Transient overexpression of TRF2 had a mild effect
on the localization of TRF1 at telomeres (Figures 2C and
2D, arrowhead), although a strong effect was noted in
a few transfected cells with very high levels of TRF2
(Figures 2C and 2D, carets). Similarly to full-length TRF2,
TRF2DB accumulated at telomeres (Figure 2E), consis-
Figure 1. Inducible Expression of TRF2 Proteins in HTC75 Cells tent with previous evidence that the basic domain is not
(A) Full-length human TRF2 (Broccoli et al., 1997) and the deletion required for the localization of this protein to chromo-
mutants TRF2DB and TRF2DBDM. The approximate position of the some ends (Broccoli et al., 1997). Cells expressing high
peptide used to raise the polyclonal aTRF2 antibody 508 is indi- levels of TRF2DB showed diminished levels of the endog-
cated. The two TRF2 deletion mutants carry an N-terminal FLAG
enous full-length TRF2 on telomeres, evidencing a weakepitope.
dominant interfering activity for this allele (Figure 2F).(B) Western analysis of the inducible expression of the three forms
TRF2DB also had a modest effect on the binding of en-of TRF2 shown in (A). Whole-cell extracts were prepared from clonal
HTC75-derived cell lines expressing the full-lengthTRF2 (clone P12), dogenous TRF1 (Figures 2G and 2H; data not shown).
TRF2DB (clone S13), TRF2DBDM (clone T4), and control cell line B27, TRF1 binds to telomeric DNA as a homodimer, requir-
which contains the empty vector. Extracts were prepared from cells ing two Myb domains for stable association with its
grown in parallel in the presence (uninduced) or absence (induced)
target site in vitro and in vivo (Bianchi et al., 1997; vanof doxycyclin for the indicated time. For each extract 20 mg of protein
Steensel and de Lange, 1997). This architecture haswas fractionated, blotted, and incubated with the primary antibodies
allowed the design of a dominant negative allele of TRF1indicated. TRF1 protein, although present in the extracts, is not
detected by the antibodies used. The minor, smaller species de- containing the dimerization domain and the NLS but
tected with antibody 508 probably represent a degradation product lacking the Myb DNA±binding domain (van Steensel and
of TRF2. de Lange, 1997). Because TRF2 carried a similar dimer-
ization domain (Broccoli et al., 1997), we asked whether
expression of an allele of TRF2 that lacked the Myb motif
Results also acted in a dominant negative fashion. Expression of
this version of TRF2 (TRF2DBDM, Figure 1A) resulted in a
Overexpression and Inhibition of TRF2 diffuse nuclear staining without evidence for accumula-
To examine the role of TRF2 at human telomeres, we tion of this protein at telomeres as expected from the
used an inducible expression system based on the cell absence of its DNA-binding domain (Figures 2I and 2K).
line HTC75, a tetracyclin-inducible derivative of the hu- The expression of TRF2DBDM clearly interfered with the
man fibrosarcoma cell line HT1080, which was pre- accumulation of the endogenous TRF2 protein at telo-
viously employed for the functional analysis of TRF1 meres (Figure 2J). Although TRF2 could be readily dem-
(van Steensel and de Lange, 1997). Using this approach, onstrated at telomeres in untransfected control cells,
we expressed full-length TRF2 protein and two trun- little or no TRF2 protein was observed at telomeric sites
cated alleles in a doxycyclin-controlled fashion (see in cells expressing the TRF2DBDM, attesting to the domi-
Experimental Procedures). One allele (TRF2DB) lacked nant negative activity of this protein. Consistent with
the N-terminal basic domain, and the second allele the earlier finding that the dimerization domains of TRF1
(TRF2DBDM) also lacked the C-terminal Myb domain (Fig- and TRF2 do not show strong interactions in vitro (Broc-
ure 1A). The two truncated proteins were endowed with coli et al., 1997), TRF2DBDM did not affect the accumula-
an N-terminal FLAG tag allowing their detection with a tion of the endogenous TRF1 protein on telomeres (Fig-
FLAG-specific monoclonal antibody. For detection of ures 2K and 2L).
full-length TRF2, a polyclonal antibody directed against
aa 16-42 was raised and affinity-purified (antibody 508;
see Figure 1). Clonal HTC75 cells transfected with each TRF2DBDM and TRF2DB Induce a Growth Arrest
in HTC75 Cellsof the three TRF2 constructs were derived and shown
to express appropriately sized TRF2 polypeptides in Whereas overexpression of full-length TRF2 had no sig-
nificant effect on the short-term growth of HTC75 cells,an inducible manner, with expression reaching plateau
levels 1±2 days postinduction (Figure 1B). Expression induction of TRF2DBDM and TRF2DB led to nearly complete
Telomere Protection by TRF2
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Figure 2. In Vivo Effects of TRF2 Mutants on Telomere Binding of Endogenous Wild-Type TRF1 and TRF2 in Transiently Transfected HeLa
Cells
(A andB) Localizationof endogenous wild-type TRF2 using antibody 508 (green/yellow) in an interphase nucleus (A) and on mitoticchromosomes
(B) of HeLa cells. DNA was stained with DAPI (shown in red).
(C and D) HeLa cells transiently transfected with wild-type TRF2 were dual-labeled for TRF2 using antibody 508 (green in [C]) and endogenous
TRF1 using mouse serum 2 (endTRF1, red in [D]). Three transfected cells overexpressing TRF2 are indicated by arrowheads; the other three
cells were probably not transfected and showed levels of endogenous TRF2 similar to untransfected control cells.
(E±H) HeLa cells transiently transfected with TRF2DB were dual-labeled for FLAG-tagged mutant protein using antibody M2 (green in [E] and
[G]) and either endogenous TRF2 (endTRF2, red in [F]) or endogenous TRF1 (endTRF1, red in [H]).
(I±L) HeLa cells transiently transfected with TRF2DBDM were dual-labeled for FLAG-tagged mutant protein using antibody M2 (green in [I] and
[K]) and either endogenous TRF2 (red in [J]) or endogenous TRF1 (red in [L]). DAPI-staining of nuclear DNA in [C]±[L] is shown in blue.
inhibition of proliferation after approximately 4 days of bridges and lagging chromosomes (Figure 4A). This phe-
notype was not observed after induction of control cellsculturing in the absence of doxycyclin (Figure 3A). This
growth arrest was accompanied by induction of senes- not expressing TRF2 proteins or in cells induced for full-
length TRF2 or TRF2DB (Figure 4B, and data not shown).cence-associated b-galactosidase (SA-b-Gal) (Dimri et
al., 1995; Figure 3B), indicating that the cells were under- We did note, however, that cells expressing TRF2DB of-
ten contained small DAPI-positive fragments that weregoing changes akin to senescence. However, the SA-
b-Gal staining of the arrested HTC75 cells was less in- detectable in anaphase (data not shown). The nature of
this phenotype is under investigation.tense than senescent primary human fibroblasts (data
not shown). In addition, the cells becameenlarged, had a The incidence of anaphase bridges and lagging chro-
mosomes was quantitated in a total of 100 anaphasevacuolated cytoplasm, and often showed multiple small
nuclei (Figure 3B), all morphological phenomena associ- cells expressing TRF2DBDM, uninduced control cells, and
in a cell line expressing TRF2DB. At day 4 after inductionated with senescence of human cells (Hayflick and
Moorhead, 1961; Sherwood et al., 1988). Consistent with of TRF2DBDM, 40% of the cells had one or more aberrant
senescence, the arrest appeared irreversible because chromosome (a bridge or a lagging chromosome), and
addition of doxycyclin to the media (to repress synthe- the culture showed on average 0.7 fusions per anaphase
sis of the TRF2 mutant proteins) on day 12 did not alter cell (Figure 4B). By contrast, the level of anaphase brid-
the morphology or the proliferative arrest of the cells ges and lagging chromosomes was low (,0.1 per cell) in
over a period of 9 days (data not shown). A substantial the uninduced control cells and in a cell line expressing
proportion of the cells in each culture failed to show TRF2DB (Figure 4B).
convincing morphological alterations and did not ex- Chromosome end fusions induced by TRF2DBDM were
press SA-b-Gal (Figure 3B). Most of these cells ex- also detected in metaphase spreads. Colcemid-treated
pressed very low levels of the TRF2 deletion derivatives cells showed dicentrics fused at one or both chromatids,
(data not shown). Collectively, the data suggested that multiple-fused chromosomes, and ring chromosomes
TRF2DB and TRF2DBDM induced a growth arrest with phe- (Figure 4C, and Table 1). After induction for 6 days, 88%
notypic characteristics of senescence. The mechanism of the metaphases showed at least one fusion (Table
of this induction and its relationship to senescence in 1). Several cells showed trains of 3 or 4 chromosomes
primary human cells is the subject of a separate study. (Figure 4C), and one cell showed as many as 30 individ-
ual fusion events (data not shown). On average there
were 2.4 fusion events per cell in cultures of the T4TRF2DBDM Induces Chromosome
End Fusions clone when induced to express TRF2DBDM for 4 or 6 days.
Uninduced T4 cells showed only 0.4 events per cellMicroscopic analysis of DAPI-stained cells expressing
TRF2DBDM revealed the frequent occurrence of anaphase (Table 1). Similarly, a second cell line (T19) expressing
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Figure 3. Growth Arrest and Induction of a
Senescent Phenotype in Response to TRF2
Mutants
(A) Graphs showing the effect of induction of
full-length TRF2 (clone P12), TRF2DB (clone
S13), and TRF2DBDM (clone T4) on the growth
of HTC75 cells. B27 is a clonal HTC75 cell
line containing the vector.
(B) Morphological changes of the indicated
HTC75 clones expressing the indicated TRF2
alleles grown for 9 days in the presence or
absence (uninduced and induced, respec-
tively) of doxycyclin. Cells were stained for
b-galactosidase activity at pH 6.0 and photo-
graphed using DIC optics.
TRF2DBDM showed an increase of the fusion frequency lagging chromosome results. Thus, our quantitation of
chromosome ends fusions probably reflects a minimalfrom 0.6 to 3.5 per cell upon induction of this dominant
negative allele of TRF2. Cells with end-to-end fusions estimate of the actual fusion frequency in the cells.
Taken together, the cytogenetic analysis indicatedwere rare ina control HTC75 cell line transfected with the
vector (B27) or in cells expressing TRF2DB (S13) (Table 1). that the removal of TRF2 from telomeres leads to loss
of telomeric protection, detectable as end-to-end fusionIn each case less then 0.3 fusions were observed per
cell, and fusions were only seen in10%±20% of the cells. in anaphase and metaphase chromosomes. It was un-
likely that this phenotype was caused by the presenceSome of these apparent fusion events may represent
fortuitous juxtaposition of chromosome ends during of excess TRF2 protein in the nucleoplasm, because
overexpression of full-length TRF2 and TRF2DB similarlyspreading. Thus, expression of the dominant negative
allele of TRF2 increases the frequency of end-to-end resulted in the presence of TRF2 throughout thenucleus,
yet induction of anaphase bridges was not noted in suchfusions by at least 10-fold. The relatively high frequency
of end-to-end fusions in the cell lines T4 and T19 in the cells (data not shown).
presence of doxycyclin is probably due to low levels of
expression of the TRF2DBDM protein in a fraction of the Fused Chromosome Ends Contain
Telomeric DNAcells. Such leaky expression was detectableby immuno-
fluorescence (data not shown) but apparently too infre- Fusion of chromosome ends has been documented in
cells containing DNA damage and in cells that havequent to be detectable by Western analysis (Figure 1B).
It should be stressed that the detection of chromo- depleted their reservoir of telomeric DNA. In those
cases, telomeric DNA is usually not detectable at thesome end fusions in anaphase and metaphase cells
likely represents an underestimate of the actual number site of fusion (Blasco et al., 1997). We therefore asked
whether the fusions in response to TRF2DBDM were simi-of events. For instance, in metaphase cells we do not
score for sister-chromatid fusions or fusions that have larly correlated with loss of telomeric DNA from individ-
ual chromosome ends. Using a fluorescein-labeled pep-been followed by chromosome breakage, and fusions
are only detectable in anaphase cells when a bridge or tide nucleic acid (PNA) [CCCTAA]3 probe specific for
Telomere Protection by TRF2
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Figure 4. Induction of Anaphase Bridges and Metaphase Fusions by TRF2DBDM
(A) Three anaphase cells displaying TRF2DBDM-induced anaphase bridges and a lagging chromosome (cell on the left). DNA was stained with
DAPI.
(B) Induction of anaphase bridges and lagging chromosomes (together referred to as ªeventsº on the y axis) in T4 cells expressing TRF2DBDM
and lack of induced fusions in S13 cells expressing TRF2DB. For each time point, one hundred anaphase cells were scored for anaphase
bridges and lagging chromosomes.
(C) Telomere fusions in metaphase chromosomes from T4 cells induced to express TRF2DBDM. Metaphase chromosomes (1) showing end-to-
end fusions stained with DAPI; several fusion events (F) and a ring chromosome (R) are indicated. Metaphase chromosomes G-banded with
trypsin (2) showing multiple end-to-end fusions. Detection of telomeric TTAGGG repeats at the sites of telomere fusion (3) (arrowheads).
TTAGGG repeats were detected using a fluorescently labeled PNA [CCCTAA]3 probe (green). DNA was stained with DAPI.
telomeric DNA, in situ hybridizations were carried out that telomeric DNA was preserved at the site of chromo-
some end fusion. In the majority of cases, the signal aton metaphase spreads from cells displaying the chro-
mosome ends fusions. The results in Figure 4C showed the fused ends was substantially stronger than that
Cell
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Table 1. Induction of Chromosome End Fusions by Mutant TRF2 Proteins
Cell Line Inducible Gene Induction Growth Period Number of Fraction with Fusions
(Days) Cells Examined Fusions Per Cell
B27 Ð 2 4 50 22% 0.2
T4 TRF2DBDM 2 4 100 38% 0.4
T4 TRF2DBDM 1 4 100 77% 2.4
T4 TRF2DBDM 1 6 50 88% 2.4
T19 TRF2DBDM 2 4 50 52% 0.6
T19 TRF2DBDM 1 4 50 78% 3.5
S13 TRF2DB 2 4 50 10% 0.1
S13 TRF2DB 1 4 50 20% 0.2
found at free telomeres, consistent with the idea that are derived from the fused chromosome ends. Because
the detection of fused ends in naked DNA argues thatthe telomeric stretches of both fused chromosome ends
had remained intact. the telomeres are held together by nucleic acid interac-
tions, we will refer to these end-joining events as telo-
meric fusions.TRF2DBDM Induces Molecular Joining
of Telomeric DNA Sequences We considered that the telomere fusions might be
mediated by (Hoogsteen) base-pairing between theTo establish whether the joining of telomeres in TRF2DBDM-
expressing cells depended on a proteinaceous bridge, G-strand overhangs at human telomeres. Such a config-
uration was previously shown to temporarily link thewe sought evidence for telomere fusion in naked geno-
mic DNA. Detection of telomeric restriction fragments termini of yeast chromosomes, which carry long G tails
in late S phase (Wellinger et al., 1993). Because this typein genomic DNA from vector control cells and cells ex-
pressing full-length TRF2 or TRF2DB showed no change of association was shown to be labile at 728C±788C, we
determined whether the fused human telomeres couldin telomere structure over the course of the induction
period (Figures 5A and 5B). By contrast, cells induced be similarly resolved by treatment at that temperature.
As shown in Figure 5F, the fused telomeres derived fromfor TRF2DBDM revealed a dramatic alteration in the pattern
of HinfI/RsaI fragments detectable with TTAGGG-repeat TRF2DBDM-expressing cells are resistant to 858C and only
melt out at higher temperatures that also denature bulkprobes (Figure 5B). A new class of longer restriction
fragments first became apparent at 4 days postinduc- DNA. This observation argues against the presence of
G-G basepairing in the 39 overhang as the main mecha-tion (Figure 5C, and data not shown), and this set of
new fragments increased in intensity but not in length nism by which telomere fusions occur. However, it is
conceivable that the human G tails form more stable G-Gover the course of the 9-day experiment. The new class
of TTAGGG-repeat fragments was observed in all four base-paired structures than yeast telomere overhangs.
The observation that the fused telomeric fragments areindependent clonal TRF2DBDM cell lines examined, and
in each case they migrated at a MW exactly twice (ratio resistant to Bal31 nuclease constitutes further evidence
against G-tail interactions in the fused telomeres. Be-of 2.0 6 0.2 [n 5 4]) that of the length of the original
population of telomeric fragments.Quantitation of geno- cause Bal31 readily cleaves single-stranded DNA, in-
cluding very short regions of unpaired sequences, suchmic blots indicated that up to 22% (average value 13.8%
6 6.1% [n 5 4]) of the TTAGGG-repeat signal was found as those occurring due to pyrimidine dimers (Linn and
Roberts, 1982), this enzyme would be expected todigestin the larger class of hybridizing material at day 9 postin-
duction. single-stranded regions within G-G base-paired telo-
meric tails and resolve the joins. Similarly, the telomereThe fact that the TRF2DBDM-induced new TTAGGG-
repeat fragments were twice the size of the original fusions were resistant to the single-stranded cleavage
activity of mung bean nuclease (data not shown). Wetelomeres suggested that these molecules might repre-
sent the chromosome end fusions that were first de- therefore favor the idea that the telomere fusions are the
result of end-to-end ligations of one or both telomerictected by cytogenetic analysis of metaphase and ana-
phase cells. Such structures would be expected to be strands.
resistant to exonuclease Bal31 treatment, whereas this
exonuclease should readily attack the new class of Telomeric Fusions Correlate with the Loss
of G-Strand Overhangslarger TTAGGG-repeat fragments if they represented
elongated telomeres. Bal31 digestion of genomic DNA Ligation of telomere termini would be unexpected if,
as proposed by Makarov et al. (1997), all or most hu-from T4 cells expressing TRF2DBDM indeed showed the
resistance of the longer TTAGGG-repeat fragments to man telomeres contain long regions of single-stranded
TTAGGG-repeat DNA. It was therefore prudent to ap-this exonuclease (Figure 5D). Quantitation of a second
data set obtained with TRF2DBDM-expressing T19 cells praise the status of the telomere termini in cells dis-
playing telomere fusions. Makarov et al. (1997) have(Figure 5E) showed that while the original telomeric loci
were gradually shortened by Bal31, the TRF2DBDM- developed a method for the quantitative detection of
single-stranded TTAGGG repeats at the ends of humaninduced longer fragments were not affected by the en-
zyme. This result indicated that the new class of chromosomes. In this technique, HinfI/RsaI-digested
nondenatured genomic DNA is annealed to labeledTTAGGG-repeat fragments did not represent elongated
telomeres. Most likely, therefore, these longer species [CCCTAA]4 oligonucleotide, and the indirectly labeled
Telomere Protection by TRF2
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Figure 5. Detection of Telomere Fusions in Naked DNA
(A) Telomere structure in clonal HTC75 lines expressing wild-type TRF2 (P clones) and in a vector control cell line (clone B27) grown in the
presence and absence of doxycyclin (2 and 1 induction, respectively) for eight population doublings.
(B) Telomere structure in clonal lines expressing the indicated deletion alleles of TRF2 grown with and without doxycyclin for 9 days (2 and
1 induction, respectively).
(C) Time course of changes in telomere structure in T4 cells induced to express TRF2DBDM and in S24 cells induced to express TRF2DB.
(D) Bal31 exonuclease digestion of DNA from T4 cells induced to express TRF2DBDM for 9 days.
(E) Quantitation of a Bal31 exonuclease experiment similar to that shown in (D) performed with DNA from T19 cells induced to express
TRF2DBDM for 9 days.
(F) Heat stability of the telomeric fusions. DNA derived from the same cells used in (D) was treated for 10 min at the indicated temperatures
and immediately loaded on an agarose gel.
(A±F) All genomic DNA samples were digested with HinfI and RsaI and analyzed by blotting using a TTAGGG repeat±specific probe (see
Experimental Procedures). The position of lHindIII DNA marker fragments (23, 9.4, 6.6, 4.4, 2.3, and 2.0 kb) is indicated next to each blot.
telomeric fragments are detected by autoradiography Using the [CCCTAA]4 probe on DNA derived from the
control cell line B27, G-strand overhangs at the ends ofof size-fractionated DNA. With this method it is possible
to evaluate the relative amount of unpaired single- wild-type telomeres were readily detected (Figure 6). To
validate the method, we verified that the probe did notstranded TTAGGG repeats in genomic DNA, but the
approach does not discriminate between loss of signal anneal to DNA that was pretreated with mung bean
nuclease and that annealing of a [TTAGGG]4 probe diddue to shortening of theG tails, complete disappearance
of G tails, or reduced detection of G tails due to G-G not result in a telomeric pattern (data not shown). When
we compared the amount of unpaired TTAGGG-repeatbase pairing in the overhangs.
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Figure 6. Expression of TRF2DBDM Causes
Loss of G-Strand Overhang Signals in the
Presence of Telomerase Activity
(A) G-strand overhang assays performed on
DNA derived from the indicated cell lines
(grown in the presence or absence of doxy-
cyclin for 9 days as indicated) expressing the
indicated TRF2 polypeptides.
(B) Time course of the loss of G tails in the
T4 clone expressing TRF2DBDM.
(C) Quantitation of the loss of G-strand over-
hangs upon induction of TRF2DBDM in two in-
dependents experiments performed with the
T4 clone. The data were derived from two
experiments similar to those shown in (B),
and the average value was plotted.
(D) Similar telomerase activity in four HTC75
clonal lines expressing the indicated TRF2
polypeptides grown for 9 days in the pres-
ence or absence of doxycyclin (2 and 1 in-
duction, respectively). For each extract, iden-
tical amounts of protein (0.5 mg) were tested
using the TRAP assay.
DNA in cells grown in the presence and absence of TRF2 Does Not Affect Telomerase Expression
The loss of G-tail sequences in TRF2DBDM-expressingdoxycyclin, no alteration in the signal was noted in three
cell lines induced to express full-length TRF2 and three cells could be explained if TRF2 is a positive regulator
of telomerase expression. We therefore examined thecell lines expressing the TRF2DB allele (Figure 6A). Simi-
larly, overexpression of TRF1 or a dominant negative telomerase levels in extracts of cells induced for the
three types of TRF2 protein used in this study andallele of TRF1 (van Steensel and de Lange, 1997) did
not affect the presence of unpaired TTAGGG repeats at matching uninduced controls using the polymerase
chain reaction (PCR)±based TRAP assay (Kim et al.,telomere termini (data not shown). By contrast, four cell
lines expressing TRF2DBDM displayed a consistent reduc- 1994). The result revealed similar levels of robust te-
lomerase activity in each cell type regardless of thetion in the amount of detectable G-tail sequences, and
no signal was present at the position of the larger termi- presence of doxycyclin in the media (Figure 6D), arguing
that the telomerase activity is not affected by TRF2 innal fragments representing the fused telomeres (Figures
6A and 6B, and data not shown). Quantitation of the this setting and that the loss of G-tail DNA occurs
through some other mechanism. We note that thesedata on four clonal cell lines showed that induction of
TRF2DBDM for 6±9 days resulted in a 40%±60% decline results do not address the possibility that TRF2 affects
the access of telomerase to telomere termini in vivo.in the total single-stranded TTAGGG-repeat signals at
chromosome ends (Figure 6C, and data not shown). As
only 10%±20% of the telomeres have become fused at Discussion
that time (Figure 5, Table 1, and data not shown), at
least some of the loss of the single-stranded G tails in This report defines TRF2 as a human telomeric protein
TRF2DBDM-expressing cells must have taken place on that is required to maintain the correct structure at telo-
mere termini, protects against end-to-end fusions, andunfused chromosome ends.
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plays a role in successful progression through the cell protrusion of single-stranded telomeric repeats that
can bind specific proteins. This terminal complex coulddivision cycle. As such, TRF2 appears to be involved in
the main functions ascribed to telomeres in somatic constitute the unique aspect of telomeres that allows
cells to distinguish natural chromosome ends from bro-human cells and is therefore a likely player in the loss of
telomere function and growth arrest that accompanies ken DNA.
The 39 extension of TTAGGG repeats at human chro-telomere shortening in normal and transformed human
cells. mosome ends are likely to serve as a binding site for
single strand±specific telomeric proteins, but the actual
factors involved in this function are still elusive. A candi-Telomere Protection by TRF2
and the Role of G Tails date activity that could cap the TTAGGG repeats has
been identified in Xenopus laevis extracts (Cardenas etA striking consequence of loss of TRF2 function is the
formation of end-to-end fusions detectable in meta- al., 1993), G-strand overhangs are bound by terminus-
specific proteins in ciliates (Gottschling and Zakian,phase and anaphase chromosomes. In contrast with the
first documented end-to-end fusions, which involved 1986; Price, 1990), and budding yeast telomeres are
protected from degradation by Cdc13p (Garvik et al.,broken chromosome ends in Drosophila melanogaster
and maize (Muller, 1938; McClintock, 1941; McClintock, 1995), a protein with G tail±binding activity in vitro (Lin
and Zakian, 1996; Nugent et al., 1996). However, human1942), the fusions induced by loss of TRF2 carry telo-
meric DNA. The presence of telomeric sequences at the homologs of these factors have not been identified yet.
It should also be noted that G-rich telomeric repeatsfusions was demonstrated by in situ hybridization, and
the fused telomeric fragments were detectable in pro- have the ability to form G-G (Hoogsteen) base-paired
folded structures with several alternative conformationstein-free genomic DNA. Yet while the telomeric TTAGGG
repeats persisted, the telomeres failed to protect the (reviewed by Henderson, 1995) that could potentially
contribute to the protection of chromosome ends.chromosome ends from fusion, indicating that the du-
plex stretch of TTAGGG repeats itself is insufficient for The telomeric fusions are probably the consequence
of processing of unmasked telomere termini by enzymestelomere protection in human cells. We conclude there-
fore that the protective function of telomeres is con- normally acting on broken DNA. A possible scenario is
that loss of TRF2 from the chromosome ends leads toferred by a nucleoprotein complex containing TRF2 and
possibly other telomeric proteins. disappearance of the G-tail overhangs and activation of
a DNA damage response by the denuded telomeres. AThe data also reveal a crucial role for TRF2 in the
maintenance of unpaired G-strand overhangs at telo- cell-cycle arrest might ensue under these conditions,
and those cells that process the offending ends intomere termini. Loss of TRF2 from telomeres, caused by
expression of the dominant negative TRF2DBDM allele, fused telomeres may preferentially continue in the cell
cycle leading to the observed metaphase abnormalitiesresulted in an approximately 50% reduction in the sin-
gle-stranded TTAGGG-repeat signal. Although G-G base and anaphase bridges. The occurrence of fused telo-
meres in turn creates problems in mitosis due to thepairing could be responsible for the diminished detec-
tion of the protrusions, we favor the view that inhibition mechanical difficulties in segregating dicentric chromo-
somes, which requires either a break in the spindle orof TRF2 results in an actual lossof G-tail DNA sequences
from human chromosome ends. Such G-tail loss could a break in a chromatid. Thus, the loss of telomeric pro-
tection may well lead to activation of checkpoints atbe the consequence of a failure toprotect the overhangs
from degradation, or it may result from a deficiency in several stages of the cell cycle. None of these cellular
responses to the telomere malfunction induced bycreating new G-tails after DNA replication.
TRF2 is the first telomere-associated protein impli- TRF2DBDM have been identified so far.
cated in the maintenance of the correct DNA configura-
tion of the telomeric 39 overhang. It was previously
Chromosome End Fusions in Cells withshown that telomerase is not involved in the mainte-
Critically Shortened Telomeresnance of G tails in yeast and mammals (Dionne and
Telomere associations have been observed by cytoge-Wellinger, 1996; Makarov et al., 1997; McElligott and
netic inspection of chromosome behavior in a numberWellinger, 1997; Wright et al., 1997), and none of the
of different settings, including senescent primary cells,other telomeric proteins identified in eukaryotes are
cells transformed with viral agents, and in a large varietyknown to affect this aspect of telomere synthesis. Al-
of tumor specimen (reviewed in de Lange, 1995). Al-though the mechanism by which TRF2 governs G-tail
though this was not always established in these studies,structure is unclear, our data indicate that changes in
data accumulated over the past decade suggest that intelomerase expression are unlikely to be involved in this
most cases where telomere associations were ob-process.
served, the telomeres may have been fairly short. In-Collectively, the data are consistent with a model
deed, in studies that measured telomere length directly,in which TRF2 protects telomeres from fusion through
there is a correlation between shortened telomeres andthe maintenance of their single-strand TTAGGG-repeat
their association in metaphase (Counter et al., 1992;overhangs. This view is consistent with the finding that
Saltman et al., 1993). Our observations on the behaviorG-strand overhangs are a universal feature of eukaryotic
of chromosome ends after loss of the duplex telomerictelomeres (reviewed in Wellinger and Sen, 1997) and
DNA-binding protein, TRF2, now suggest a molecularidentification of G strand±binding proteins in several
mechanism underlying these telomere associations. Wesystems. Thus, one of the mainobjectives of the transac-
tions at telomeres may be to create and maintain a propose that when the telomeres reach a critical minimal
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length theirability to recruit sufficient TRF2 is diminished
and end-to-end fusions result. The length setting at
which this aspect of telomere function becomes com-
promised is not yet clear.
Telomeres and Cellular Senescence
Expression of two mutant TRF2 polypeptides induced
a growth arrest in the human fibrosarcoma cells used
in this study. This arrest had several features consistent
with the induction of senescence, including a specific
Figure 7. The Role of Human Telomeric Proteins in Telomere Pro-
cellular morphology, expression of a b-galactosidase tection and Telomere Length Regulation
activity correlated with senescence, and the irreversible TRF1 is depicted as a negative regulator of telomere maintenance,
nature of the arrest. Further analysis will be required proposed to act by inhibiting telomerase at individual chromosome
to establish whether this senescent-like phenotype in ends (van Steensel and de Lange, 1997). TRF2 is involved in the
protection of chromosome ends by inhibiting end-to-end fusionsthese transformed cells is actually directly related to
(this report). Thus, in the process of adding TTAGGG repeats, te-the replicative senescence described in primary human
lomerase synthesizes binding sites for two proteins onto chromo-cells. Regardless of the exact nature of this phenotype,
some ends, one of which ensures telomere integrity and the other
the results indicate that transformed human cells are regulates the length of the telomeres. The relative position and
rather sensitive to the status of their telomeres and that abundance of TRF1 and TRF2 on human telomeres is not known.
interference with telomere function could inhibit prolifer-
ation of malignant cells.
Two mechanisms for the induction of the observed As a result, the TRF2-bound end of the transfected linear
growth arrest can be entertained at this stage. Because plasmid may be prevented from undergoing the recom-
the growth arrest in HTC75 cells is accompanied by bination reaction that normally leads to chromosome-
chromosomal abnormalities, one possibility is that the internal integration of transfected DNA. Recombination
arrest is a response to DNA damage arising from the of the other (nontelomeric) end of the transfected DNA
altered TRF2 activity at telomeres. The second possibil- with a resident chromosomal locus will then lead to
ity is that a specific pathway exists allowing cells to the observed chromosome fragmentation. Telomerase
evaluate the status of their telomeres. For instance, the subsequently elongates the telomere seed to form a
presence of the basic N terminus of TRF2 on telomeres fully functional telomere.
may be required to suppress cellular senescence. Over-
expression of a mutant protein lacking this domain Mechanisms of Telomere Function
would then be expected to induce arrest by displacing A general view of the logic underlying the function of
the endogenous TRF2. Similarly, the strong dominant human telomeres is now emerging (Figure 7). Human
negative activity of TRF2DBDM would result in telomeres telomerase has long been understood to maintain the
lacking the basic N-terminal domain of TRF2 and cause terminal sequences of human chromosome ends and
an arrest signal. Such a mechanism would allow cells thus counter DNA attrition with cell divisions. The need
to monitor the length of their telomeres and initiate a for telomere length maintenance is particularly obvious
growth arrest and senescence program in response to in immortalized cells and in the germline. However, the
critical shortening of the telomeres. current results reveal a second function for telomerase.
In addition to balancing the terminal sequence loss that
accompanies DNA replication, telomerase actually en-Requirements for Telomere Formation
in Human Cells sures the continued presence of TRF2-binding sites at
chromosome ends by synthesizing arrays of TTAGGGTransfection of TTAGGG repeats into human cells leads
to efficient de novo formation of fully functional telo- repeats. Because TRF2 is required to prevent telomere
fusions, telomerase thus maintains the protective activ-meres (Farr et al., 1991). We have previously found an
excellent correlation between the binding specificity of ity of telomeres by constantly replenishing TRF2-binding
sites that are lost from telomere termini with DNA repli-TRF1 and the cis-acting requirements for de novo telo-
mere formation in human cells (Hanish et al., 1994), sug- cation. This second function of telomerase critically de-
pends on the sequence of the telomeric repeats it syn-gesting that the acquisition of TRF1 might be an essen-
tial step in telomere healing. However, the subsequent thesizes, and this view predicts that the exact sequence
of the telomerase products is a key aspect of themecha-cloning of TRF2 revealed that this protein has the same
sequence preference as TRF1 (Broccoli et al., 1997), nism of telomere function.
In this regard, mutations of the telomerase templateraising the possibility that TRF2 rather than TRF1 is
involved in the conversion of the transfected DNA into RNA in Tetrahymena thermophila has given rise to dra-
matic cellular phenotypes (Yu et al., 1990; Kirk et al.,a functional telomere. The finding that TRF2 is important
for the protection of chromosome ends now hints at a 1997), including occasional anaphase bridges that may
well represent telomere fusions of the type reportedlikely scenario for de novo telomere formation in human
cells. Acquisition of TRF2 may be one of the early steps here. Tetrahymena telomeric-binding proteins that could
have been displaced by the altered telomeric repeatsas the transfected telomere seed enters the nucleus.
According to the current data, TRF2 has the ability to have not yet been identified. It will be of interest to
correlate the effects of altering the telomerase templateprotect the TTAGGG repeats from ligation to other DNA.
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pellets (z4 million cells) were resuspended in 200 ml buffer C (20sequence in mammalian cells (for example, Marusic et
mM Hepes-KOH [pH 7.9], 420 mM KCl, 25% glycerol, 0.1 mM EDTA,al., 1997) with the binding specificity of TRF2.
5 mM MgCl2, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluo-Addition of TTAGGG repeats to chromosome ends
ride, 0.2% Nonidet P-40, 1 mg leupeptin per ml, 1 mg pepstatin per
also ensures the binding of a second telomeric protein, ml, 1 mg aprotinin per ml), incubated for 30 min and centrifuged for
TRF1, that is proposed to act as a negative regulator 10 min in an Eppendorf microfuge at 14,000 g. The supernatant was
dialyzed 2±5 hr against 100 ml of buffer D (20 mM Hepes-KOH [pHof telomerase, modulating the length of the TTAGGG
7.9], 100 mM KCl, 20% glycerol, 0.2 mM EDTA, 0.2 mM EGTA, 0.5repeats arrays at chromosome ends (van Steensel and
mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride), frozen inde Lange, 1997). Thus, the telomerase-mediated main-
liquid nitrogen, and stored at 2808C. Protein content of the extractstenance of telomeric TTAGGG repeats secures a func-
was measured using the Bradford assay (BioRad, Hercules, CA) and
tional and regulated telomeric complex required for the using bovine serum albumin as a standard.
integrity of chromosome ends.
Western Blotting
Experimental Procedures Twenty micrograms of whole-cell extract proteins were separated
on 10% SDS-polyacrylamide gels and transferred to nitrocellulose
Expression Vectors by electroblotting. Ponceau S±staining confirmed equal loading of
The cDNA encoding full-length human TRF2 was placed under the the samples. Blots were preincubated 30 min in 10% nonfat milk
tetracyclin-controlled promoter by cloning the EcoRI fragment of powder and 0.5% Tween-20 in PBS. All subsequent incubations
plasmid phTRF216-1 (Broccoli, 1997) into vector pUHD10-3, re- and washing steps were carried out in 0.1% nonfat dry milk powder
sulting in plasmid pTethTRF2. To facilitate the creation of constructs and 0.1% (w/v) Tween-20 in PBS. Blots were incubated for 12±16
encoding truncated proteins with an N-terminal FLAG tag, expres- hr at 48C with either anti-FLAG antibody M2 or anti-TRF2 antibody
sion vector pTetNFLAG was constructed by inserting a linker encod- 508, followed by three 10 min washing steps. Next, blots were incu-
ing a FLAG tag and an EcoRI site into the SacII and BamHI sites bated 45 min with horseradish peroxidase conjugated sheep-anti-
of pUHD10-3. Next, TRF2DB (containing aa 45-500) and TRF2DBDM mouse (Jackson) or donkey-anti-rabbit antibody (Amersham) and
(containing aa 45-454) were each cloned into the EcoRI and BamHI washed three times for 10 min. Bound antibody was detected using
sites of pTetNFLAG (in-frame with the FLAG-tag) by PCR cloning, the enhanced chemiluminescence kit (Amersham).
using Pfu-polymerase, plasmid phTRF216-1 as template, with 59TTG
AATTCGAGGCACGGCTGGAAGAG39 as forward primer for both
Immunofluorescence Labeling and Microscopyconstructs, 59CGGGATCCTGTTTCAGTTCATGCCAA39 as backward
The HeLaI.2.11 cell line, a subclone of HeLaI (Saltman et al., 1993)primer for TRF245-500, and 59CGGGATCCTCATTCTACAGTCCACTTC
bearing telomeres of more than 25 kb (data not shown), wasTGCT39 as backward primer for TRF245-454.
transfected by electroporation with pTethTRF2, pTetFLAGhTRF2DB,
or pTetFLAGhTRF2DBDM together with the tTA-expression vectorInduction of TRF2 Polypeptides in HTC75 Cells
pUHD15-1 (Gossen and Bujard, 1992). Cells were grown for 24 hr onThe empty vector pUHD10-3 and the pUHD10-3-derived constructs
Alcian blue±coated coverslips in the absence of doxycyclin. Fixationfor expression of the TRF2 alleles were each cotransfected with
and immunostaining were carried out as described (Chong et al.,neomycin resistance plasmid pNY-HI (H. Tommerup and T. d. L.,
1995; van Steensel and de Lange, 1997). TRF2 was detected withunpublished data) into cell line HTC75 using the calcium phosphate
polyclonal antibody 508 (see above), raised, and affinity-purifiedcoprecipitation. HTC75 is a hygromycin-resistant HT1080-derived
against an N-terminal peptide of TRF2. The FLAG-epitope tag wasclonal cell line that stably expresses the tetracyclin-controlled trans-
detected with the M2 anti-FLAG monoclonal antibody (Eastmanactivator (tTA) (Gossen and Bujard, 1992; van Steensel and de
Kodak). TRF1 was detected with a mouse polyclonal serum (#2)Lange, 1997). Transfected cells were grown in the presence of doxy-
directed against the full-length protein (S. Smith and T. d. L., unpub-cyclin (100 ng/ml)and G418 (600 mg/ml). Foreach construct, approx-
lished data) or with antibody 371C2 (van Steensel and de Lange,imately 25 G418-resistant cell lines were isolated by ring cloning
1997). Rabbit antibodies were detected with fluorescein isothiocya-and tested for expression of TRF2 polypeptides after 24 hr of induc-
nate (FITC)± or Cy3-conjugated donkey-anti-rabbit antibodiestion by omission of doxycyclin from the media (doxycyclin acts
(Jackson ImmunoResearch). Mouse antibodies were detected withas a repressor of gene expression in this system). Expression of
FITC-conjugated donkey-anti-mouse antibody (Jackson). ControlTRF2DBDM and TRF2DB were tested by immunofluorescence micros-
experiments indicated that secondary antibodies did not show anycopy and western blotting using anti-FLAG antibody M2 (Eastman
cross-reaction (data not shown). To exclude that binding of anti-Kodak); expression of wild-type TRF2 was tested by gelshift assays
TRF1 (371C2) (van Steensel and de Lange, 1997) and anti-TRF2using a TTAGGG-repeat probe and by western blotting using affinity-
(508) antibodies to endogenous TRF proteins was prevented bypurified serum 508 (see below). All clones were grown in DMEM
anti-FLAG antibody M2 through steric hindrance, we preincubatedsupplemented with 10% bovine calf serum or bovine fetal serum
the cells overnight with 371C2 or 508 before adding M2.and 150 mg G418 per ml. All clones were grown in parallel with or
Micrographs were recorded on a Zeiss Axioplan microscope withwithout doxycyclin (100 ng/ml).
a Kodak DCS200 digital camera. Images were noise-filtered, cor-
rected for background, and merged using Adobe Photoshop.Polyclonal Antibody against TRF2
A 28-mer peptide (pep28) encompassing amino acid residues 16-
42 of human TRF2 with an additional N-terminal cysteine was syn- Cell Growth Curves and b-Galactosidase Assay
thesized (BioSynthesis, Lewisville, TX) and conjugated to malei- Cells were plated in duplicate at various densities (z0.1±4.0 3 106
mide-activated keyhole limpet haemocyanin (KLH, Pierce, Rockford, cells/15 cm dish) the day before the experiment. On day 0, all plates
IL). Serum from a rabbit immunized with the pep28-KLH conjugate were washed three times with medium containing G418 (150 mg/
was affinity-purified against pep28 cross-linked to SulfoLink cou- ml) with or without doxycyclin (100 ng/ml). On indicated days, cells
pling gel (Pierce) using standard procedures (Harlow and Lane, were harvested and counted, and cell pellets were frozen at 2808C
1988). The resulting purified antibody 508 reacts specifically with for isolation of genomic DNA. Whole-cell extracts were prepared
TRF2 in western blotting and immunofluorescence labeling assays. from dishes grown in parallel. In most experiments, cells were split
The antibody does not cross-react with TRF1 (data not shown). at day 4 (1:32±1:4) for day 6 and day 9 time points.
Cells induced for 9 days were stained for b-galactosidase using
the method described in Dimri et al. (1995) butwith phosphate bufferWhole-Cell Extracts
Cells grown in 10 cm dishes were washed with 5 ml cold phosphate- instead of citrate/phosphate buffer. Cells were washed in PBS (pH
7.2), fixed for 5 min in 2% formaldehyde/0.2% glutaraldehyde solu-buffered saline (PBS), harvested by scraping in 1 ml PBS per dish,
and centrifuged 2 min in an Eppendorf microfuge at setting 4,000 tion in PBS , washed again in PBS (pH 7.2), and stained with X-gal
(1 mg/ml) in 150 mM NaCl, 2 mM MgCl2, 5 mM K3Fe(CN)6, 5 mMg. Subsequent steps were all carried out on ice or at 48C. The cell
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K4Fe(CN)6, and 40 mM NaPi (pH 6.0, pH 4.0 or pH 7.0) for 6±12 hr approximately 1.5±30 kb. DNA samples from cells grown with or
without doxycyclin were always analyzed in parallel and run on theat 378C.
same gel.
Chromosome Analysis in Metaphase and Anaphase Cells
Four to six days after induction (as indicated in the text) cells were TRAP Assay
incubated with 0.1 mg demecolcine per ml for 90 min, harvested by Reactions were performed with whole-cell extracts as described
trypsinization, incubated for 7 min at 378C in 0.075 M KCl, and fixed elsewhere (Broccoli et al., 1995). Protein concentrations in the ex-
in freshly prepared methanol:glacial acidic acid (3:1 vol/vol). Cells tracts were determined by Bradford assay (BioRad), and 0.5 mg
were stored at 48C and when needed dropped onto wet slides and protein was used per extract. RNase digestions were done in parallel
air-dried. to the untreated reaction by addition of 0.2 mg DNase-free RNAse
For DAPI staining of DNA, slides with metaphase spreads were A to the telomerase extension reaction.
incubated 10 min in 0.5 mg 4', 6-diamino-2-phenylindole (DAPI)
(Sigma) per ml PBS, washed for 2 min in PBS, and mounted in Acknowledgments
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